Posted on August 4, 2008 by crimsoncanary
The FDA has approved The Medicines Company’s ca channel blocker Cleviprex for the IV treatment of hypertension
Filed under: Calcium Channel | Tagged: AstraZeneca, ca channel, Calcium Channel, Clevelox, Clevidipine, Cleviprex, The Medicines Company | Leave a Comment »
Posted on July 14, 2008 by crimsoncanary
Phase III data shows that The Medicines Company’s drug Cleviprex (clevidipine butyrate) is effective and safe in the rapid treatment of acute hypertension after cardiac surgery.
Filed under: Calcium Channel | Tagged: antagonist, Calcium Channel, Clevidipine, Cleviprex, The Medicines Company | Leave a Comment »
Posted on April 29, 2008 by crimsoncanary
A forthcoming Phase III trial of Clevidipine (Clevelox, Cleviprex) for Acute Hypertension and Intracerebral Hemorrhage is being carried out by The Medicines Company.
Filed under: Calcium Channel, Ion Channel | Tagged: ca channel, Calcium Channel, Clevelox, Clevidipine, Cleviprex, Ion Channel, The Medicines Company | Leave a Comment »